InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (2 ops.)
Insider track record
CFODisclosed buys
3
Disclosed sells
2
T+90 hit rate
50%
T+90 mean return
+0.7%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Pieper Steven, Chief Financial Officer. Director active across 2 companies, notably Xeris Pharmaceuticals INC. Aggregated, 19 disclosures have been logged. Breakdown: 3 buys · 2 sells. Total volume traded: €471k. Activity tracked since 28 July 2021. The latest transaction was disclosed on 6 July 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations19 total
17,400 shares@ US$8.50Common StockSEC:0001875714-26-000007:0
27,600 shares@ US$8.5245Common StockSEC:0001875714-26-000007:1
110,750 shares@ US$3.5657.2% of flowCommon StockSEC:0001867096-25-000024:0
32,059 shares@ US$3.6117.0% of flowCommon StockSEC:0001867096-25-000012:0
19,483 shares@ US$1.554.3% of flowCommon StockSEC:0001867096-24-000190:0
3,460 shares@ US$2.111.0% of flowCommon StockSEC:0001867096-24-000168:0
450,000 shares0Common StockSEC:0001867096-24-000018:0
28,000 shares@ US$1.957.5% of flowCommon StockSEC:0001867096-23-000149:0
Ideal exit: 16 Aug 2024 (T+270)
750,000 shares0Common StockSEC:0001867096-23-000022:0
200,000 shares0Common StockSEC:0001867096-22-000012
200,000 shares0Common StockSEC:0001867096-22-000012:0
25,000 shares@ US$1.99676.5% of flowCommon StockSEC:0001867096-21-000075
Ideal exit: 7 Aug 2022 (T+270)
25,000 shares@ US$1.99670.0033% mcap50.0% of flowCommon StockSEC:0001867096-21-000075:0
Ideal exit: 7 Aug 2022 (T+270)
23,775 sharesCommon StockSEC:0000899243-21-039324:0
23,775 sharesCommon StockSEC:0000899243-21-039253
23,775 sharesCommon StockSEC:0000899243-21-039324
23,775 sharesCommon StockSEC:0000899243-21-039253:0
100,000 shares0Common StockSEC:0000899243-21-030664
100,000 shares0Common StockSEC:0000899243-21-030664:0
19 of 19 declarations
About Pieper Steven
Pieper Steven is Chief Financial Officer at XERIS PHARMACEUTICALS INC and Xeris Biopharma Holdings, Inc. In this role, he is responsible for financial management and budgeting strategy for these companies. His expertise in finance allows him to optimize financial performance and ensure regulatory compliance. Steven plays a key role in strategic planning and financial results analysis.
